Search
for
Sort by
Research 901–930 of 1000+
- Long-term safety and efficacy of mirabegron and solifenacin in combination compared with monotherapy in patients with overactive bladder: SYNERGY II study
- Clinical and Imagistic Aspects in Dog’s Hyperadrenocorticism Determined by Pituitary and Adrenal Nodules with Secretory Function
- Experience of using of Sonirid Duo in treatment of patients with BPH
- Re: Associations Between Variants in the Cyclooxygenase 2 Enzyme Gene (PTGS2) and Development of Benign Prostate Enlargement
- Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer?
- Клинико-морфологическая характеристика ПЖ на фоне лечения ингибиторами 5-альфаредуктазы при ДГПЖ
- Оптимизация подходов консервативной терапии доброкачественной гиперплазии предстательной железы ингибиторами 5-альфаредуктазы. Клинико-морфологическое исследование
- New drugs: Agalsidase alfa
- Eficacia de la combinación de doxazosina y finasterida en la hipertrofia benigna de próstata
- Analysis of Cost-effectiveness of 4 Kinds of Projects for Drug Therapy in the Treatment of BPH
- 保法止（非那雄胺）治疗雄激素性脱发
- [The effect of nizoral on the function of the hypothalamo-hypophyseal-ovarian system in virilism].
- Functional medical approach and management for long COVID
- Health is Wealth & Wealth is Pugos Nutrition
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Oral zinc therapy for zinc deficiency-related telogen effluvium
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- The lowest effective dose of botulinum toxin in detrusor sphincter dyssynergia
- Modeling the pharmacodynamics of nandrolone doping drug and implications for anti‐doping testing
- A Case of Gynecomastia Induced by Use of Doxazosin
- Diazepam-Induced Amnesia for Cardioversion
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Telocytes in human skin – are they involved in skin regeneration?
- Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- JAK inhibitors and alopecia areata